These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1451735)

  • 1. Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: the role of hippocampal dopamine D1 receptors.
    Alam AM; Starr MS
    Eur J Pharmacol; 1992 Nov; 222(2-3):227-32. PubMed ID: 1451735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: the role of hippocampal D2 receptors.
    Alam AM; Starr MS
    Neuroscience; 1993 Mar; 53(2):425-31. PubMed ID: 8098511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
    Turski WA; Cavalheiro EA; Ikonomidou C; Bortolotto ZA; Klockgether T; Turski L
    Synapse; 1990; 5(2):113-9. PubMed ID: 2137942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-1 dopamine agonist administration reduces the threshold for convulsions produced by pilocarpine.
    Barone P; Palma V; Parashos SA; Marin C; Chase TN; Campanella G
    Boll Soc Ital Biol Sper; 1989 Apr; 65(4):337-41. PubMed ID: 2570598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite effects of stimulation of D1 and D2 dopamine receptors on the expression of motor seizures in mouse and rat.
    al-Tajir G; Chandler CJ; Starr BS; Starr MS
    Neuropharmacology; 1990 Jul; 29(7):657-61. PubMed ID: 1974713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D1 receptor modulation of pilocarpine-induced convulsions.
    Barone P; Parashos SA; Palma V; Marin C; Campanella G; Chase TN
    Neuroscience; 1990; 34(1):209-17. PubMed ID: 2139189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate-dopamine interactions in the production of pilocarpine motor seizures in the mouse.
    Starr MS; Starr BS
    J Neural Transm Park Dis Dement Sect; 1993; 6(2):109-17. PubMed ID: 7906944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticonvulsant action of SCH 23390 in the striatum of the rat.
    al-Tajir G; Starr MS
    Eur J Pharmacol; 1990 Dec; 191(3):329-36. PubMed ID: 1982269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
    Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX; Bergstrom DA; Ruskin DN; Walters JR
    Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D1 and D2 receptors mediate opposite functions in seizures induced by lithium-pilocarpine.
    Barone P; Palma V; DeBartolomeis A; Tedeschi E; Muscettola G; Campanella G
    Eur J Pharmacol; 1991 Mar; 195(1):157-62. PubMed ID: 1829682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of dopamine receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats.
    Rezayof A; Zarrindast MR; Sahraei H; Haeri-Rohani A
    J Psychopharmacol; 2003 Dec; 17(4):415-23. PubMed ID: 14870954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic modulation of lithium/pilocarpine-induced status epilepticus in rats.
    George B; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1997 Sep; 19(7):481-8. PubMed ID: 9413831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM; Fernández M; Jantos H
    Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of D1- and D2-dopamine agonists on neocortical and hippocampal EEG activity of rat brain: modulation of rimcazole effect.
    Verma A; Kulkarni SK; Nayar U
    Methods Find Exp Clin Pharmacol; 1993 Oct; 15(8):515-25. PubMed ID: 7905945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade.
    Ramos M; Goñi-Allo B; Aguirre N
    Neuropsychopharmacology; 2005 Dec; 30(12):2180-91. PubMed ID: 15841107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Place conditioning with the dopamine D1-like receptor agonist SKF 82958 but not SKF 81297 or SKF 77434.
    Abrahams BS; Rutherford JD; Mallet PE; Beninger RJ
    Eur J Pharmacol; 1998 Feb; 343(2-3):111-8. PubMed ID: 9570457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of low calcium induced epileptiform discharges in the hippocampus by dopamine D1 receptor agonist, SKF 38393.
    Smiałowski A
    Brain Res; 1990 Sep; 528(1):148-50. PubMed ID: 2147120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro.
    Momiyama T; Todo N; Sasa M
    Br J Pharmacol; 1993 Aug; 109(4):933-40. PubMed ID: 8104652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.